Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Status:
Recruiting
Trial end date:
2028-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is twofold. First, is to determine whether vancomycin is effective
in the early treatment of Biliary Atresia (BA) and Primary Sclerosing Cholangitis (PSC), and
if so, by what mechanism. Secondly, to characterize human intestinal microbial communities
and their interactions with the host.